Copy For Citation
Demirel G., ALPERTUNGA B., ÖZDEN S.
PHARMACEUTICAL BIOLOGY, vol.53, no.9, pp.1302-1310, 2015 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
53
Issue:
9
-
Publication Date:
2015
-
Doi Number:
10.3109/13880209.2014.976714
-
Journal Name:
PHARMACEUTICAL BIOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.1302-1310
-
Keywords:
Clone 9 cells, cytotoxicity, NRK-52E cells, TUMOR-SUPPRESSOR GENES, FUSARIUM MYCOTOXINS, SPHINGOLIPID METABOLISM, EPIGENETIC EVENTS, IN-VIVO, B-1, CANCER, MECHANISMS, HYPOMETHYLATION, DAMAGE
-
Çukurova University Affiliated:
No
Abstract
Context: Fumonisin B1 (FB1) is a mycotoxin produced by Fusarium verticillioides (Sacc.) Nirenberg (Nectriaceae) mold that contaminates maize and other agricultural products. Although the effects of FB1 on sphingolipid metabolism are clear, little is known about early molecular changes associated with FB1 carcinogenicity.